NKARTA INC. - COMMON STOCK
1.7850
11-3月-25 15:19:39
15 分の遅延
株式
-0.0150
-0.83%
本日の幅
1.7050 - 1.8200
ISIN
N/A
ソース
NASDAQ
-
Nkarta Reports Third Quarter 2021 Financial Results and Business Update
10 11 2021 16:01:01 提供 Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conferences
04 11 2021 08:04:00 提供 Nasdaq GlobeNewswire
-
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
07 10 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Nkarta to Present Preclinical Data from Engineered NK Cell Platform at SITC 36th Annual Meeting
01 10 2021 08:08:00 提供 Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conference
14 9 2021 08:32:00 提供 Nasdaq GlobeNewswire
-
Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
12 8 2021 16:02:00 提供 Nasdaq GlobeNewswire
-
Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters
14 7 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Nkarta to Present at Upcoming Investor Conference
16 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term
14 6 2021 07:01:00 提供 Nasdaq GlobeNewswire
-
Nkarta Announces June 2021 Investor Conference Schedule
25 5 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Nkarta Reports First Quarter 2021 Financial Results and Business Progress
13 5 2021 16:02:00 提供 Nasdaq GlobeNewswire
-
28 4 2021 08:02:00 提供 Nasdaq GlobeNewswire
-
Nkarta Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Business Progress
25 3 2021 16:03:00 提供 Nasdaq GlobeNewswire
-
Nkarta Announces February and March 2021 Investor Conference Schedule
17 2 2021 16:03:00 提供 Nasdaq GlobeNewswire